Keyphrases
Influenza Virus
100%
NOD-like Receptors
100%
Influenza-like Illness
100%
Aged Mice
50%
Lung Injury
35%
Acute Lung Injury
28%
Specific Intent
21%
Viral Respiratory Infections
14%
Viral Pneumonia
14%
Clinically Significant
14%
NLRP3 Inflammasome
14%
Viral Infection
14%
Viral Elimination
7%
Pediatric Acute Lung Injury
7%
Healthy children
7%
Critically Ill children
7%
Virus Pneumonia
7%
Underlying Medical Conditions
7%
Paediatric Physician
7%
Severe Influenza
7%
NLRP3 Inflammasome Inhibitor
7%
Clearance Rate
7%
Scientific Advisory Committee
7%
Physician-scientist
7%
Additional Training
7%
Career Goals
7%
Hypothesis-driven
7%
Viral Clearance
7%
Interleukin-1β
7%
Innate Immune Response
7%
In Vitro Model
7%
Respiratory Infection
7%
Pediatric
7%
NOD-like Receptor Protein 3 (NLRP3)
7%
Paucity
7%
Interleukin-18 (IL-18)
7%
United States
7%
Healthy Adults
7%
Adult Mice
7%
Increased Incidence
7%
Alveolar Epithelial Cells
7%
Clinical Tool
7%
Immune Function
7%
Macrophage Cells
7%
Pediatric Population
7%
Contagious Virus
7%
Sustained Activation
7%
Host-pathogen Interactions
7%
Vulnerable Populations
7%
Mouse Model
7%
Risk Factors
7%
Research Laboratories
7%
Inflammation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nucleotide Binding Oligomerization Domain Like Receptor
100%
Virus Infection
100%
Influenzavirus A
100%
Receptor Protein
29%
Acute Lung Injury
29%
Virus Pneumonia
17%
Infection
17%
Inflammasome
17%
Viral Respiratory Tract Infection
11%
Viral Clearance
11%
Mouse Model
5%
Infectious Agent
5%
Normal Human
5%
Inflammation
5%
Interleukin 18
5%
Respiratory Tract Infection
5%
Immunology and Microbiology
Influenzavirus A
100%
Viral Disease
100%
NOD-like Receptor
100%
NLRP3 Inflammasome
17%
Viral Clearance
11%
Innate Immune System
5%
Macrophage
5%
Interleukin-1
5%
Leadership
5%
Mouse Model
5%
Clearance
5%
Normal Human
5%
Vulnerable Population
5%
Host-Pathogen Interaction
5%
Interleukin 18
5%
Immunity
5%